一个国际性的,基于专家的,德尔菲共识文件,关于腹腔大动脉动脉瘤管理中的有争议的问题
Kosmas I Paraskevas1, Marc L Schermerhorn2, Stephan Haulon3
1Department of Vascular Surgery, Red Cross Hospital, Athens, Greece.
Journal of vascular surgery
|August 15, 2024
概括
专家一致认为,每年病例数量对于腹腔大动脉动脉瘤 (AAA) 修复中心至关重要. AAA查可能仍然有效且具有成本效益,建议在内血管修复 (EVAR) 后进行终身监测.
科学领域:
- 血管外科 血管外科
- 建立医学共识 建立医学共识
- 公共卫生查 公共卫生查
背景情况:
- 腹腔大动脉动脉瘤 (AAA) 的管理存在未解决的临床问题,原因是文献矛盾.
- 关于AAA管理的现有数据不足或有争议,需要专家指导.
研究的目的:
- 为腹腔大动脉动脉瘤 (AAA) 管理中有争议的话题提供临床指导.
- 在AAA患者护理的关键问题上建立专家共识.
主要方法:
- 一个三轮的德尔菲共识进程,涉及44名国际专家.
- 匿名解决了AAA管理的6个预定义主题,每轮100%的响应率.
主要成果:
- 95.4%对AAA维修中心 (开放或EVAR) 基本最低年度案例数量达成协议.
- 75.0%的人相信AAA查计划的临床和成本效益.
- 在EVAR后,终身监测达到了81.9%的共识.
- 79.7%的人支持考虑65岁的吸烟女性接受AAA查.
结论:
- 这个德尔菲共识提供了关于几个未解决的AAA管理问题的专家指导.
- 在特定主题上缺乏共识,例如AAA修复值和EVAR后DVT预防,这表明需要进一步研究的领域.
相关概念视频
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...


